1.	Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 21 to 49 Sponsor: Other Protocol IDs: 12377, NCT01276704
2.	Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000644401, UPCC-03309, IRB# 806733, NCT00955942
3.	Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 21 to 50 Sponsor: Other Protocol IDs: 11-0575, RPCI-I-81906, I-81906, NCT00794989
4.	FLAX FX, A Research Study of the Effects of Flaxseed Lignans on Colon Health Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 20 to 45 Sponsor: NCI, Other Protocol IDs: FHCRC IR 7532, NCT01619020
5.	Biomarkers in Post-Menopausal Women Receiving Flaxseed Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Active Age: 45 to 75 Sponsor: NCI, Other Protocol IDs: I 216812, NCI-2012-01246, U01CA161809, NCT01698294